Rosiglitazone RECORD study: glucose control outcomes at 18 months.

Diabet Med · 2007 · PMC1974811 · PMID 17517066

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

At 18 months, the apparently greater reductions in FPG in the rosiglitazone groups did not reach statistical significance ( Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.